HK Stock MarketDetailed Quotes
08307 MEDICSKIN
- 0.190
- 0.0000.00%
Market Closed Nov 8 16:08 CST
75.38MMarket Cap-23750P/E (TTM)
0.000High0.000Low0Volume0.190Open0.190Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)396.74MShares0.22252wk High6.79P/B75.38MFloat Cap0.09252wk Low--Dividend TTM396.74MShs Float3.824Historical High--Dividend LFY0.00%Amplitude0.018Historical Low--Avg Price4000Lot Size--Div YieldTTM--Div Yield LFY
MEDICSKIN Key Stats
All
YOY
| (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 15.64%-3.12M | ---- | -183.76%-3.7M | ---- | 236.45%4.42M | ---- | 124.73%1.31M | ---- | 39.12%-5.31M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | -32.39%-658K | ---- | -11.43%-497K | ---- | 26.64%-446K | ---- | 30.03%-608K | ---- | -164.94%-869K | ---- |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | -19.35%396K | ---- | -41.55%491K | ---- | --840K | ---- |
| Dividend (income)- adjustment | ---- | ---- | -216.67%-19K | ---- | ---6K | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | -75.94%289K | ---- | -28.77%1.2M | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | -75.94%289K | ---- | 900.83%1.2M | ---- |
| Revaluation surplus: | ---- | ---- | 53.28%-57K | ---- | -215.09%-122K | ---- | --106K | ---- | ---- | ---- |
| -Other fair value changes | ---- | ---- | 53.28%-57K | ---- | -215.09%-122K | ---- | --106K | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | 99.66%-3K | ---- | -5,294.12%-883K | ---- | --17K | ---- |
| -Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---3K | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | -4,141.18%-687K | ---- | --17K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---196K | ---- | ---- | ---- |
| Depreciation and amortization: | 0.71%9.39M | ---- | -4.17%9.33M | ---- | -0.85%9.73M | ---- | -6.10%9.81M | ---- | 127.61%10.45M | ---- |
| Financial expense | -34.66%509K | ---- | --779K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Unrealized exchange loss (gain) | -32.16%384K | ---- | 203.66%566K | ---- | -17.42%-546K | ---- | -205.44%-465K | ---- | -2.65%441K | ---- |
| Special items | -79.10%144K | ---- | 9,742.86%689K | ---- | -85.42%7K | ---- | -76.92%48K | ---- | -65.04%208K | ---- |
| Operating profit before the change of operating capital | -6.17%6.65M | ---- | -47.27%7.08M | ---- | 32.91%13.43M | ---- | 44.85%10.11M | ---- | 503.53%6.98M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 124.40%527K | ---- | -1,610.49%-2.16M | ---- | 170.44%143K | ---- | -2,437.50%-203K | ---- | 99.34%-8K | ---- |
| Accounts receivable (increase)decrease | 74.47%-85K | ---- | -766.00%-333K | ---- | 163.16%50K | ---- | -94.19%19K | ---- | 1,008.33%327K | ---- |
| Accounts payable increase (decrease) | 243.81%777K | ---- | 118.43%226K | ---- | -158.49%-1.23M | ---- | 399.43%2.1M | ---- | -300.57%-700K | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | -37.41%343K | ---- | --548K | ---- |
| Financial assets at fair value (increase)decrease | --1.37M | ---- | ---- | ---- | 61.51%-388K | ---- | ---1.01M | ---- | ---- | ---- |
| Special items for working capital changes | 472.82%1.8M | ---- | 93.78%-482K | ---- | -230.99%-7.76M | ---- | -133.49%-2.34M | ---- | -12.33%7M | ---- |
| Cash from business operations | 154.61%11.04M | 228.42%2.83M | 1.83%4.33M | -53.66%862K | -52.76%4.26M | -66.69%1.86M | -36.28%9.01M | -33.89%5.58M | 164.12%14.14M | 681.41%8.45M |
| Other taxs | 96.76%-10K | ---- | -1,065.63%-309K | ---- | -76.64%32K | ---- | -82.18%137K | ---- | 167.34%769K | ---- |
| Interest paid - operating | 34.66%-509K | ---- | -96.72%-779K | ---- | ---396K | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 223.97%10.52M | 228.42%2.83M | -16.60%3.25M | -53.66%862K | -57.45%3.89M | -66.69%1.86M | -38.65%9.15M | -33.89%5.58M | 253.99%14.91M | 681.41%8.45M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -0.82%365K | 15.85%95K | 21.05%368K | -35.94%82K | -34.76%304K | -69.95%128K | -36.51%466K | 27.93%426K | 123.78%734K | 85.00%333K |
| Dividend received - investment | ---- | ---- | 216.67%19K | ---- | --6K | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | 90.30%-365K | -40.00%-126K | -2,266.04%-3.76M | -60.71%-90K | 29.96%-159K | 62.42%-56K | -37.58%-227K | -88.61%-149K | 98.32%-165K | ---79K |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | --200K | --200K | ---- | ---- |
| Purchase of fixed assets | 39.26%-1.4M | 17.20%-621K | -17.05%-2.3M | 53.68%-750K | 14.79%-1.97M | -7.43%-1.62M | -35.41%-2.31M | 6.86%-1.51M | 57.18%-1.7M | 37.60%-1.62M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | -99.47%213K | -99.47%213K | 772.89%40.15M | --40.15M |
| Adjustment items of investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.01M | ---- | ---- |
| Net cash from investment operations | 75.38%-1.4M | 13.98%-652K | -212.84%-5.68M | 51.00%-758K | -9.67%-1.81M | 15.33%-1.55M | -104.24%-1.65M | -104.71%-1.83M | 538.27%39.02M | 1,690.41%38.79M |
| Net cash before financing | 475.42%9.12M | 1,995.19%2.18M | -216.89%-2.43M | -66.77%104K | -72.27%2.08M | -91.67%313K | -86.11%7.49M | -92.05%3.76M | 1,249.63%53.93M | 3,578.42%47.24M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -63.64%196K | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---9.92M | ---9.92M | ---- | ---- | -2,594.73%-19.43M | -2,594.73%-19.43M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---13.04M | ---11.03M | ---- | ---- |
| Other items of the financing business | -6.99%-7.21M | ---- | ---6.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -6.99%-7.21M | 0.03%-3.85M | 61.60%-6.74M | 72.38%-3.85M | 16.56%-17.55M | 6.26%-13.95M | 22.75%-21.03M | 35.83%-14.88M | -1,132.03%-27.23M | -1,201.81%-23.18M |
| Effect of rate | 80.00%18K | 103.33%22K | -95.10%10K | -1,322.22%-660K | 257.89%204K | 63.64%54K | 187.69%57K | 151.56%33K | 84.78%-65K | ---64K |
| Net Cash | 120.82%1.91M | 55.40%-1.67M | 40.74%-9.17M | 72.51%-3.75M | -14.27%-15.47M | -22.59%-13.63M | -150.70%-13.54M | -146.23%-11.12M | 1,400.73%26.7M | 3,124.53%24.06M |
| Begining period cash | -64.68%5M | -64.68%5M | -51.88%14.16M | -51.88%14.16M | -31.42%29.42M | -31.42%29.42M | 169.50%42.91M | 169.50%42.91M | -15.08%15.92M | -15.08%15.92M |
| Items Period | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%346K | --346K |
| Cash at the end | 38.54%6.93M | -65.63%3.35M | -64.68%5M | -38.46%9.75M | -51.88%14.16M | -50.20%15.85M | -31.42%29.42M | -20.96%31.82M | 169.50%42.91M | 106.53%40.26M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data